Novelion Therapeutics Funding: $22M Raised

Novelion Therapeutics funding overview

Novelion Therapeutics is based in Vancouver, Canada. Novelion Therapeutics has raised $22M in total disclosed funding. That places its disclosed total in the $1M–$25M range. The round record for Novelion Therapeutics runs through 2016; nothing later has been disclosed. Investors on record include Deerfield, Armistice Capital, Broadfin Capital, Healthcare Value Capital, JW Asset Management, K2 & Associates Investment Management and 3 others. 9 distinct backers are named across the disclosed rounds.

Novelion Therapeutics at a glance

Total raised: $22M
Latest round date: November 2016
Headquarters: Vancouver, Canada
Notable investors: Deerfield, Armistice Capital, Broadfin Capital, Healthcare Value Capital, JW Asset Management, K2 & Associates Investment Management, Sarissa Capital, Jason Aryeh

Frequently asked about Novelion Therapeutics funding

How much has Novelion Therapeutics raised?: Novelion Therapeutics has raised $22M in total disclosed funding across the rounds on record.
Who has invested in Novelion Therapeutics?: Deerfield, Armistice Capital, Broadfin Capital, Healthcare Value Capital, JW Asset Management, K2 & Associates Investment Management are named among the investors backing Novelion Therapeutics.
What was the latest Novelion Therapeutics funding round?: No round stage has been disclosed for Novelion Therapeutics.
Where is Novelion Therapeutics based?: Novelion Therapeutics is based in Vancouver, Canada.
When did Novelion Therapeutics last raise?: The last disclosed Novelion Therapeutics round closed in November 2016.

Novelion Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Vancouver below to benchmark round size and investor mix.

Novelion Therapeutics Funding: $22M Raised

Novelion Therapeutics funding overview

Novelion Therapeutics at a glance

Frequently asked about Novelion Therapeutics funding

Companies related to Novelion Therapeutics (20)

Browse related funding lists (2)